The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(Methoxycarbonyl)phenyl 4-guanidinobenzoate ID: ALA1195245
Chembl Id: CHEMBL1195245
Max Phase: Preclinical
Molecular Formula: C16H15N3O4
Molecular Weight: 313.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms from Alternative Forms(1): 4-(Methoxycarbonyl)Phenyl 4-Guanidinobenzoate Methanesulfonate
Canonical SMILES: COC(=O)c1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1
Standard InChI: InChI=1S/C16H15N3O4/c1-22-14(20)10-4-8-13(9-5-10)23-15(21)11-2-6-12(7-3-11)19-16(17)18/h2-9H,1H3,(H4,17,18,19)
Standard InChI Key: NIBWPUGZCXNNPC-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 313.31Molecular Weight (Monoisotopic): 313.1063AlogP: 2.00#Rotatable Bonds: 4Polar Surface Area: 114.50Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.11CX LogP: 2.61CX LogD: 1.84Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.34Np Likeness Score: -0.45
References 1. Franco FM, Jones DE, Harris PK, Han Z, Wildman SA, Jarvis CM, Janetka JW.. (2015) Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets., 23 (10): [PMID:25882520 ] [10.1016/j.bmc.2015.03.072 ] 2. Zhao J, Sun N, Gao Y, Lv D, Liu Y, Jiang Y, Dong G, Chen Q, Li W, Zhou Y, Zhu J, Sheng C, Lv J. (2014) Discovery of novel guanidinophenylpyrazole human acrosin inhibitors by molecular hybridization, 5 (10): [10.1039/C4MD00160E ]